Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immuno-regulatory effects of hydroxychloroquine in experimental autoimmune thyroiditis.

Immunopharmacology and immunotoxicology·2026
Same author

β, β-Dimethylacrylshikonin Triggers Caspase-Mediated Cell Apoptosis via Heme Oxygenase-1 Upregulation and ERK/p38 Activation in Prostate Cancer.

Journal of cellular and molecular medicine·2026
Same author

Effect of tonsillar fossa suturing in adolescents and adults: a systematic review and meta-analysis.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026
Same author

Impact of <i>IGF2BP2</i> genetic variants and expression levels with the progression of endometrial cancer.

International journal of medical sciences·2026
Same author

Sustained DNA Hypomethylation Induced by a DNA Methyltransferase 1 Inhibitor Triggers Apoptosis in Thyroid Cancer Cells.

Drug development research·2026
Same author

Association of TIMP2 Gene Variants With Development of Diabetic Retinopathy.

In vivo (Athens, Greece)·2026
Same journal

Serum sialic acid is independently associated with cerebrovascular atherosclerotic stenosis severity and total vascular burden: A retrospective cohort study.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Measurement of low-density lipoprotein cholesterol and other circulating lipids in Brazil: a systematic literature review.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Reference intervals for venous blood gas measurement in a healthy Chinese population.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Multiplex methylation marker analysis for ctDNA detection in liquid biopsies from anal cancer patients: an HPV-independent approach.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Development and validation of patient-based exponentially weighted moving average quality control models for three antipsychotic drugs and their metabolites by LC-MS/MS.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Comparing conventional correction formulas and machine learning-based prediction of ionized calcium.

Clinica chimica acta; international journal of clinical chemistry·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

New markers in pneumonia.

Chao-Wen Cheng1, Ming-Hsien Chien, Shih-Chi Su

  • 1Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|February 7, 2013
PubMed
Summary
This summary is machine-generated.

New biomarkers show promise for improving pneumonia diagnosis and treatment. These indicators, reflecting the body's response to infection, could aid clinicians in making faster, more informed decisions for better patient outcomes.

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Related Experiment Videos

Last Updated: May 14, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Area of Science:

  • Infectious Diseases
  • Clinical Diagnostics
  • Biomarker Discovery

Background:

  • Pneumonia remains a leading cause of infectious disease mortality globally and a common hospital-acquired infection.
  • Current diagnostic and treatment strategies have limitations, contributing to high mortality rates.
  • Delayed antibiotic therapy, due to diagnostic delays, is a major factor in poor outcomes.

Purpose of the Study:

  • To review emerging biomarkers for pneumonia diagnosis, risk stratification, and management.
  • To categorize novel biomarkers into distinct groups for clarity.
  • To briefly introduce methods for new biomarker identification.

Main Methods:

  • Literature review of recent studies on pneumonia biomarkers.
  • Categorization of biomarkers into: microorganisms/derivatives, inflammation mediators, inflammation response proteins, and stress-sensing proteins.
  • Overview of biomarker discovery approaches.

Main Results:

  • Various biomarkers reflecting biological responses to infection show potential in pneumonia management.
  • Categorized biomarkers include microbial products, inflammatory mediators, acute-phase proteins, and stress-related proteins.
  • New approaches for biomarker identification are emerging.

Conclusions:

  • No single biomarker currently provides a definitive pneumonia diagnosis.
  • Potential biomarkers can supplement existing clinical practices to enhance decision-making.
  • Further research and validation are needed to integrate these biomarkers into routine care.